user avatar
Michael J. Blaha
@MichaelJBlaha
Preventive Cardiology, Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, @CiccaroneCenter
Johns Hopkins Hospital
Joined February 2013
Posts
  • user avatar
    I just head some great news! The great Dr. Pam Taub has been promoted to Professor at UCSD. Congratulations to Professor Taub, a leader in cardiometabolic disease! @CBallantyneMD @NMHheartdoc @DLBHATTMD @DrMarthaGulati @ErinMichos @ASPCardio
  • user avatar
    I think these SELECT top line results are the most important for preventive cardiology since the JUPITER trial. Incredible implications for our field. ml-eu.globenewswire.com/Resource/Downl…
  • user avatar
    I will be recruiting for a new preventive cardiology / cardiometabolic medicine fellow @CiccaroneCenter for 2023. Now that Match is done, futures are being planned. If interested in this 1 or 2 year position, please DM me.
  • user avatar
    It is time again to recruit for our Cardiometabolic Fellowship in the Johns Hopkins Ciccarone Center. This is dedicated for those with SPECIFIC interest in preventive cardiology and cardiometabolic disease. If interested, please DM me and I will ask for your CV and PS.
  • user avatar
    Here is a nice summary of the new paper on warranty of CAC=0 from MESA.
  • user avatar
    Very High Coronary Artery Calcium (CAC ≥ 1000) and Association with CVD Events, Non-CVD Outcomes, and Mortality: Results from The Multi-Ethnic Study of Atherosclerosis (MESA)
  • user avatar
    1/14 To facilitate discussion, I put together brief a tweetorial on the DANCAVAS trial while between sessions here in Barcelona. @NEJM link:
  • user avatar
    New in @JACCJournals: Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing in At-Risk Young Adults sciencedirect.com/science/articl…
  • user avatar
    All cardiologists should push back against incorrect comments that CAC costs $800-1000. That is even high for CTA. CAC most commonly costs $75-200. @CNN cnn.it/2OEgP0G
  • user avatar
    US FDA approves Jardiance® (empagliflozin) to treat adults living with heart failure with reduced ejection fraction prn.to/3yYAOPT
  • user avatar
    So happy for my two star senior research fellows! @HassanMirbolouk matched at Yale, and @solaorimoloye matched at Vanderbilt (one of my alma maters). Continues the great @CiccaroneCenter tradition! Can't wait to see development of my next group.
  • user avatar
    Just received my first copy. Great new textbook to check out, very comprehensive 111 chapters covering cardiovascular medicine and surgery.
  • user avatar
    Replying to @dmljmd and @JAMAInternalMed
    One of the most uninformed pieces I have ever read. The wrong message to send patients in 2021. Instead, we should follow our many great guidelines on this topic.
  • user avatar
    A Simple Approach to the Identification of Guideline-Based Coronary Artery Calcium percentiles - MESA. sciencedirect.com/science/articl…